The National Institute for Health and Care Excellence (NICE) has released updated guidance stating that Hormone Replacement Therapy (HRT) does not affect life expectancy for women managing menopausal symptoms. Following an in-depth analysis, NICE found that while HRT may have some associated risks, including a slight increase in breast cancer risk, it does not shorten overall lifespan. The guidelines recommend that healthcare professionals provide tailored information to patients, emphasizing the benefits of HRT, such as reduced fracture risks. Additionally, NICE suggests combining therapy with talking therapies for optimal patient support.